Table 4. Risks of postoperative complications in patients with new postoperative atrial fibrillation.
OR or HR | 95% CI | P-value | ||
---|---|---|---|---|
Composite of in-hospital MAEs | ||||
In-hospital death | ||||
In-hospital myocardial infarction | 4.08 | 2.18–7.61 | <0.0001 | |
In-hospital revascularization | ||||
In-hospital stroke | 4.1 | 0.99–16.88 | 0.051 | |
Prolonged mechanical ventilation (>72h) | 15.17 | 4.31–53.46 | <0.0001 | |
Acute kidney injury | 1.77 | 0.73–4.28 | 0.21 | |
One year MACCEs | 2.93 | 1.76–4.87 | <0.001 | |
Death | 11.91 | 1.06–133.32 | 0.04 | |
Myocardial infarction | 3.56 | 2.06–6.28 | <0.0001 | |
Revascularization | ||||
Stroke | 4.7 | 1.29–17.15 | 0.02 | |
Other postoperative outcomes | ||||
Prolonged ICU stay (>72h) | 2.35 | 1.36–4.06 | 0.002 | |
In-hospital wound problem | 1.6 | 0.52–4.97 | 0.41 | |
Bleeding-related reoperation | 2.66 | 0.76–9.35 | 0.13 | |
Time to extubation, hr | 0.013 | |||
Length of stay at ICU, hr | <0.001 | |||
CKMBmax | <0.001 | |||
Troponin Imax | 0.001 | |||
NT-proBNPmax | 0.07 |
OR indicates odds ratio; HR, hazard ratio; CI, confidence interval; MAEs, major adverse events; MACCEs, major adverse cardiovascular and cerebral events; ICU, intensive care unit;; CKMBmax, postoperative maximum creatine kinase-MB; NT-proBNPmax, postoperative maximum N-terminal pro-brain natriuretic peptide.